R&D Project Manager
Posted on: 15 Mar 2021
Cambridge, MA
Job Description
Job Description
The R&D Project manager is responsible for partnering with R&D Project Leaders (RDPLs) to lead R&D Project Teams (RDPTs) through the effective, cross-functional planning and execution of drug development programs and strategic R&D initiatives.
Ensures high quality project planning and execution by facilitating the identification and tracking of R&D project team goals, and developing and maintaining the integrated project schedule within the Project Portfolio Management system (Planisware i.e. Clarity system). Identifies, tracks, communicates, and manages critical path activities, and holds team members accountable for functional delivery of plans. Liaises with the RDPT finance partner for budget planning and tracking and collaborates with the Strategic Planning and Operations (SPO) team to assess team resources & forecasting, identify resourcing gaps, and mitigate issues as necessary.
Supports effective decision making through identification and management of risks and issues, and the creation of project-level timeline scenarios to enable the assessment of project acceleration and other trade-offs. Drives the preparation of the RDPT for R&D governance meeting interactions and is the go-to SME for navigating governance and resourcing processes.
Proactively and effectively manages project team collaboration, communication planning, and reporting within the team and across key cross-functional stakeholders to ensure timeline completion of deliverables. This includes high quality RDPT meeting management (agenda management, meeting material preparation and organization, scheduling, meeting minutes, and effective action/decision/issue management).
Qualifications
Minimum 3-5 years of experience in an R&D scientific and/or R&D project management role
Proficient understanding of preclinical (early research through IND) R&D drug development processes in one or more drug modalities and biopharmaceutical industry
Outstanding ability to communicate effectively both verbally and in writing; ability to communicate to a broad range of stakeholders
Ability to work independently, navigate ambiguity, adapt to change and make rapid, disciplined decisions to enable agile execution
Commitment to a customer-first culture and motivation to solving complex problems and leading teams to success
Proven ability to network and collaborate across multiple teams with flexible, positive attitude and ability to get results
Proficiency with integrated timeline/gantt chart development and technical experience with project management systems & collaboration tools is a plus (e.g. Planisware, Microsoft Project, OnePager Pro/Express, MS Teams, O365 Sharepoint)
Education :
* Bachelors Degree required scientific focused degree is a plus
* PMP certification or demonstrated Project Management experience is a plus
Additional Information
All your information will be kept confidential according to EEO guidelines.
Biogen
Cambridge, MA
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases worldwide. The company offers TECFIDERA, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for the treatment of multiple sclerosis (MS); SPINRAZA for the treatment of spinal muscular atrophy; and FUMADERM for the treatment of plaque psoriasis. It also provides BENEPALI, an etanercept biosimilar referencing ENBREL; FLIXABI, an infliximab biosimilar referencing REMICADE; and IMRALDI, an adalimumab biosimilar referencing HUMIRA. In addition, the company offers RITUXAN for the treatment of non-Hodgkin's lymphoma, chronic lymphocytic leukemia (CLL), rheumatoid arthritis, two forms of ANCA-associated vasculitis, and pemphigus vulgaris; RITUXAN HYCELA for non-Hodgkin's lymphoma and CLL; GAZYVA to treat CLL and follicular lymphoma; and OCREVUS for the treatment of primary progressive MS and relapsing MS, and other anti-CD20 therapies.
Further, it is involved in developing BIIB098, Opicinumab, and BIIB061 for MS and neuroimmunology; Aducanumab, Elenbecestat, BAN2401, BIIB092, BIIB076, and BIIB080 to treat Alzheimer's disease and dementia; BIIB092 and BIIB054 for treating Parkinson's disease and movement disorders; BIIB067, BIIB078, and BIIB110 to treat neuromuscular disorders; BIIB093, TMS-007, and Natalizumab to treat acute neurology; BIIB104 for treating neurocognitive disorders; BIIB074 and BIIB095 for pain; and Dapirolzumab pegol, BG00011, and BIIB059 for treating other diseases, which are under various stages of development.
The company offers products through its sales force and marketing groups. Biogen Inc. has collaboration agreements with Genentech, Inc., Eisai Co., Ltd., Alkermes Pharma Ireland Limited, Bristol-Myers Squibb Company, Acorda Therapeutics, Inc., AbbVie Inc., C4 Therapeutics, University of Pennsylvania, Applied Genetic Technologies Corporation, and others. The company was founded in 1978 and is headquartered in Cambridge, Massachusetts.
-
IndustryBiotechnology
-
No. of Employees7,800
-
Website
-
Jobs Posted445
